Labosys
Payments companies reported to CMS as associated with Labosys. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Labosys, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Labosys
These are the largest totals companies reported as associated with Labosys. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Galla | Mobile, AL | Interventional Cardiology | $621.42 |
| Craig Walker | Houma, LA | Interventional Cardiology | $587.23 |
| Kristian Hochberg | Charleston, SC | Vascular Surgery | $566.49 |
| Pradeep Nair | Houma, LA | Interventional Cardiology | $433.80 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $413.33 |
| Lawrence Goldstein | Napa, CA | Vascular Surgery | $394.11 |
| Andrew Nimmich | Napa, CA | Vascular Surgery | $346.18 |
| Brian Keyashian | Walnut Creek, CA | Vascular Surgery | $304.51 |
| Douaglas Kyrouac | Saint Louis, MO | Internal Medicine | $280.90 |
| Jon Christopher Orlino | Walnut Creek, CA | Vascular Surgery | $252.10 |
Prescribed Labosys?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.